These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

117 related items for PubMed ID: 4801679

  • 1. Experimental models for the in vivo evaluation of enzyme induction properties of drugs.
    Bianchi C, Tomasi L, Bacci MC, Molino C, Bonardi G, Vidi A, Coppi G.
    Arzneimittelforschung; 1973 Dec; 23(12):1681-9. PubMed ID: 4801679
    [No Abstract] [Full Text] [Related]

  • 2. The diphasic action of halothane on the oxidative metabolism of drugs by the liver. An in-vitro study in the rat.
    Brown BR.
    Anesthesiology; 1971 Sep; 35(3):241-6. PubMed ID: 5095536
    [No Abstract] [Full Text] [Related]

  • 3. Further studies on the metabolism of drugs by subfractions of hepatic microsomes.
    Gram TE, Rogers LA, Fouts JR.
    J Pharmacol Exp Ther; 1967 Mar; 155(3):479-93. PubMed ID: 6022622
    [No Abstract] [Full Text] [Related]

  • 4. Species difference in the inhibition of drug metabolism by liver microsomes by different inhibitors.
    Kato R, Onoda K, Takayanagi M.
    Jpn J Pharmacol; 1969 Sep; 19(3):438-50. PubMed ID: 4390624
    [No Abstract] [Full Text] [Related]

  • 5. Time course differences in the metabolism of drugs by hepatic microsomes from rats, rabbits and mice.
    Gram TE, Fouts JR.
    J Pharmacol Exp Ther; 1966 Jun; 152(3):363-71. PubMed ID: 5922307
    [No Abstract] [Full Text] [Related]

  • 6. Differences in the oxidative metabolism of drugs by liver microsomes.
    Kato R, Takayanagi M, Oshima T.
    Jpn J Pharmacol; 1969 Mar; 19(1):53-62. PubMed ID: 5306221
    [No Abstract] [Full Text] [Related]

  • 7. Studies on age difference in mice for the activity of drug-metabolizing enzymes of liver microsomes.
    Kato R, Takanaka A, Onoda K.
    Jpn J Pharmacol; 1970 Dec; 20(4):572-6. PubMed ID: 5312939
    [No Abstract] [Full Text] [Related]

  • 8. Inhibition of microsomal drug metabolism by 2-((2-(4-pyridyl)-methyl)-thio)-benzimidazole (H-718).
    Varga F, Fischer E, Szily T.
    Acta Physiol Acad Sci Hung; 1973 Dec; 44(3-4):227-34. PubMed ID: 4807135
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Sex differences in the effects of abnormal physiological states on the metabolism of drugs by rat liver microsomes.
    Kato R, Gillette JR.
    J Pharmacol Exp Ther; 1965 Nov; 150(2):285-91. PubMed ID: 4285416
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Pharmacological investigations of 4-prenyl-1,2-diphenyl-3,5-pyrazolidinedione (DA 2370). 3. General pharmacological properties.
    Bianchi C, Bonardi G.
    Arzneimittelforschung; 1972 Jan; 22(1):Suppl 1a:196+. PubMed ID: 5067191
    [No Abstract] [Full Text] [Related]

  • 16. Strain differences in the metabolism and action of drugs in mice and rats.
    Kato R, Onoda K, Takanaka A.
    Jpn J Pharmacol; 1970 Dec; 20(4):562-71. PubMed ID: 5312938
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.